FDA expands use of kidney cancer drug belzutifan
Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved ...
Tech Times
Unproven Autism Drug Surged 2,000% After Federal Briefing: Pregnant Patients Avoided Safe Painkiller
Leucovorin autism prescriptions surged 2,000% after a September 2025 White House briefing promoted the unapproved drug ...
UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency
The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data ...
“Truly evil” FDA rejection of gene therapy overturned after Trump official ousted
A gene therapy for Huntington’s disease has a new path toward approval from the Food and Drug Administration after the ouster ...
UniQure to seek approval for Huntington's therapy after FDA U-turn, shares skyrocket
Dutch drugmaker ​UniQure said ‌on Wednesday the ​U.S. ​Food and Drug ⁠Administration ​has agreed ​that data from a ​mid-stage ...
FDA approves the first new sunscreen in over 20 years
The chemical can work better and feel better ...
MedCity News
Amgen Defends Rare Disease Drug in FDA Crosshairs
Amgen is standing behind a rare disease drug that the FDA wants off the market due to safety concerns and alleged clinical trial manipulation, and its defense will include a new analysis of the ...
RFK Jr.'s Peptide Plan Explained, Why Most Substances Already Cleared but Few Are Fully Approved
RFK Jr. announced a major peptide reclassification plan in 2026. Here's what's actually cleared and what still needs FDA sign ...